Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma
Patrick Hallaert(National Institutes of Health), Isaac Brownell(National Institute of Arthritis and Musculoskeletal and Skin Diseases), John W Roman(Walter Reed National Military Medical Center), Jennifer L. Marté(National Cancer Institute), Alexandre Reuben(The University of Texas MD Anderson Cancer Center), Nicholas Logemann(Walter Reed National Military Medical Center), Mairead Baker(National Institutes of Health), Natasha T. Hill(National Institutes of Health), James L. Gulley(Center for Cancer Research), Courtney W. Hudgens(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
|Clinical Cancer Research|2018|415